PRECISION MEDICINE SUMMIT: A HIMSS EVENT
WASHINGTON, DC, May 17-18, 2018
Richard Milani currently serves as the Chief Clinical Transformation Officer and Vice-Chairman of the Department of Cardiology at Ochsner Health System and Professor of Medicine, at Ochsner Clinical School – The University of Queensland School of Medicine in New Orleans, Louisiana. After receiving his Internal Medicine training at the University of Florida, Dr. Milani completed fellowships in Critical Care Medicine at the University of Florida, Preventive Medicine and Clinical Epidemiology at Harvard University (Massachusetts General Hospital), and Cardiovascular Diseases at Ochsner Clinic Foundation. Dr. Milani’s research interests involve healthcare delivery, information systems, clinical decision support, and chronic disease management and prevention. He is the author of the book Death and Dollars: Solving the Epidemic of Chronic Disease as well as author or co-author of over 500 medical publications including 20 book chapters and he serves as a frequent lecturer for healthcare systems and Fortune 500 companies.
Over the past 30 years, Richard Milani, MD, has received acclaim for his accurate forecasts of the future of healthcare delivery, his innovations in medicine and his contributions to new technologies that will change how all of us maintain our health.
In a 2016 interview, a reporter asked Dr. Milani to describe the future of healthcare in three words. His response: Omics. Tailored. Connected.
In this opening keynote, Dr. Milani examines what’s required to drive clinical innovation and how precision and personalized medicine will shape the future of healthcare, enhancing our ability to improve health and reduce disease. And how three words will make a world of difference.
Despite amazing technological breakthroughs for precision medicine, government champions, and continuing and significant investment, challenges exist related to appropriate regulatory guidelines, suitable reimbursement, and the education of healthcare professionals.
In this kick-off leadership panel, our experts discuss the current state of precision medicine and how to overcome these challenges. Additionally, they’ll address how to realistically: